Skip to main content

A tale of two Ebola stocks: Chimerix and Tekmira

The Ebola story has played out in the stock market recently largely on the backs of two companies: drugmakers Chimerix and Tekmira.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.